Digoxin oral solution Rx
Generic Name and Formulations:
Digoxin 0.05mg; per mL; lime-flavored; contains alcohol 10%.
Roxane Laboratories, Inc.
Indications for Digoxin oral solution:
Mild-to-moderate heart failure (with a diuretic and an ACE inhibitor when possible). Control of ventricular response rate in chronic atrial fibrillation.
Individualize: see literature. Initially 0.003mg/kg per day. Monitor digoxin levels.
Individualize: see literature. >2yrs: initially 0.01mg/kg per day. Monitor digoxin levels.
Renal dysfunction: reduce dose. Sinus node disease. Incomplete AV block. Accessory AV pathway (Wolff-Parkinson-White syndrome). Heart failure with preserved LV ejection fraction (eg, restrictive cardiomyopathy, constrictive pericarditis, amyloid heart disease, acute cor pulmonale, hypertrophic cardiomyopathy). Electrical cardioversion. Acute MI. Toxicity risk increased by hypokalemia, hypomagnesemia, hypercalcemia, diabetes. Hypocalcemia may nullify effects. Thyroid disease. Hypermetabolic states. Monitor digoxin levels, electrolytes, renal function. Elderly. Children. Infants. Pregnancy (Cat.C). Nursing mothers.
May be potentiated by antiarrhythmics (amiodarone, propafenone, quinidine), calcium channel blockers (verapamil, diltiazem, nifedipine, nitrendipine), captopril, telmisartan, spironolactone, carvedilol, epoprostenol, diclofenac, indomethacin, tramadol, ketoconazole, itraconazole, rabeprazole, clarithromycin. May be antagonized by rifampin, acarbose, miglitol, cyclosporine, colestipol, St. John's Wort, albuterol. Increased risk of arrhythmias with sympathomimetics. Others (see literature).
GI upset, anorexia, CNS effects (eg, blurred or yellow vision, or mental disturbances, confusion, headache, weakness, dizziness, apathy), gynecomastia, rash, heart block, arrhythmias (esp. children).
- Paleo Diet: Should It Stay in the Stone Age?
- Risks and Recommendations: The Use of NSAIDs in Patients With Cardiovascular Disease
- Neurological Complications Caused by "Skinny Jeans"
- What's the Secret to Longevity? Lessons from "Blue Zones" Worldwide
- Peanut Allergy Drug Designated Breakthrough Therapy